Revenue, 2023 (US$M)
$0.0
Forecast, 2030 (US$M)
$0.0
CAGR, 2024 - 2030
0%
Report Coverage
Singapore

Singapore mycoplasma testing market, 2018-2030 (US$M)

Singapore

Singapore mycoplasma testing market highlights

  • An overview of the Singapore mycoplasma testing market trends heading towards 2030. The market in Singapore generated a revenue of USD 6.5 million in 2023 and is expected to reach USD 15.4 million by 2030.
  • The overall growth of the Singapore market from 2023 to 2030. The Singapore market is expected to grow at a CAGR of 13.2% from 2024 to 2030.
  • A look at the Singapore market revenues per segment in 2023. In terms of segment, kits & reagents was the largest revenue generating product in 2023.
  • The segment witnessing the fastest revenue growth within the market. Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.

Mycoplasma testing market data book summary

Market revenue in 2023USD 6.5 million
Market revenue in 2030USD 15.4 million
Growth rate13.2% (CAGR from 2023 to 2030)
Largest segmentKits & reagents
Fastest growing segmentKits & Reagents
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Kits & Reagents, Services
Key market players worldwideThermo Fisher Scientific Inc, Lonza Group Ltd, Merck KGaA, Charles River Laboratories International Inc, Asahi Kasei Corp, Sartorius AG, Eurofins Scientific SE, PromoCell GmbH, ATCC, InvivoGen

Other key industry trends

  • In terms of revenue, Singapore accounted for 0.7% of the global mycoplasma testing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan mycoplasma testing market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 120.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Mycoplasma Testing Market Scope

Mycoplasma testing market segmentation & scope
Instruments
PCR Assays
Nucleic Acid Detection Kits
Stains
Elimination Kits
Standards & Controls
Others Kits & Reagents
Services
PCR
ELISA
Direct Assay
Indirect Assay
Microbial Culture Techniques
Enzymatic Methods
Cell Line Testing
Virus Testing
End of Production Cells Testing
Other Applications
Pharmaceutical & Biotechnology Companies
Cell Banks
Contract Research Organizations
Academic & Research Institutes
Others End Use

Mycoplasma Testing Market Companies

Name Profile # Employees HQ Website

Singapore mycoplasma testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mycoplasma testing market will help companies and investors design strategic landscapes.


Kits & reagents was the largest segment with a revenue share of 50.77% in 2023. Horizon Databook has segmented the Singapore mycoplasma testing market based on instruments, kits & reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.


  • Singapore Mycoplasma Testing Product Outlook (Revenue, USD Million, 2018-2030)
    • Instruments
    • Kits & Reagents
      • PCR Assays
      • Nucleic Acid Detection Kits
      • Stains
      • Elimination Kits
      • Standards & Controls
      • Others Kits & Reagents
    • Services
  • Singapore Mycoplasma Testing Technology Outlook (Revenue, USD Million, 2018-2030)
    • PCR
    • ELISA
    • Direct Assay
    • Indirect Assay
    • Microbial Culture Techniques
    • Enzymatic Methods
  • Singapore Mycoplasma Testing Application Outlook (Revenue, USD Million, 2018-2030)
    • Cell Line Testing
    • Virus Testing
    • End of Production Cells Testing
    • Other Applications
  • Singapore Mycoplasma Testing End Use Outlook (Revenue, USD Million, 2018-2030)
    • Pharmaceutical & Biotechnology Companies
    • Cell Banks
    • Contract Research Organizations
    • Academic & Research Institutes
    • Others End Use

Reasons to subscribe to Singapore mycoplasma testing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Singapore mycoplasma testing market databook

  • Our clientele includes a mix of mycoplasma testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Singapore mycoplasma testing market , including forecasts for subscribers. This country databook contains high-level insights into Singapore mycoplasma testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Singapore mycoplasma testing market

Singapore Mycoplasma Testing Market Outlook Share, 2023 & 2030 (US$M)

Singapore mycoplasma testing market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more